FSA and HSA Eligibility Rules for Online Allergy Drops Versus In-Office Shots
Online drops offer easier pre-tax payment planning, while shots may have better insurance coverage.

Both online prescription allergy drops and in-office allergy shots qualify for FSA and HSA spending, but eligible does not mean equally easy to pay for. Drops require a physician prescription, and neither a limited-purpose FSA nor a dependent care FSA covers them. For patients with an account that qualifies, drops delivered through telehealth make it easier to plan pre-tax spending and keep records, while insurance may cover more of the cost of shots.
How FSA and HSA accounts work, and where they differ in ways that affect allergy care
A health savings account, or HSA, requires enrollment in a high-deductible health plan, or HDHP. Its funds roll over each year, can be invested and grow tax-free, and can be withdrawn tax-free for qualified expenses. A flexible spending account, or FSA, is offered through an employer regardless of health plan type and generally works on a “use it or lose it” basis. Some employers allow an FSA grace period or limited carryover, so the specific plan determines how much room a patient has when allergy care crosses plan years.
A Health Reimbursement Arrangement, or HRA, is employer-funded and follows the same IRS medical-expense rules for allergy care. A limited-purpose FSA, or LPFSA, does not cover allergy immunotherapy. A dependent care FSA, or DCFSA, also falls outside allergy care, despite sharing the FSA name.
What the IRS actually requires for an allergy expense to qualify
IRS Publication 502, Medical and Dental Expenses, sets out the rules for what counts as a medical purpose. IRS Publication 969, Health Savings Accounts and Other Tax-Favored Health Plans, explains the rules for tax-favored accounts. An expense must be primarily for diagnosing, curing, mitigating, treating, or preventing disease, and that purpose must be documented. A brand name does not establish medical necessity. The same test connects an allergy consultation, a prescribed treatment, and a product bought to reduce exposure at home.
That distinction becomes concrete with a HEPA air purifier. Because it also serves a general household purpose, it does not qualify automatically as an allergy expense. A Letter of Medical Necessity, or LMN, from a licensed provider must state the diagnosed condition and the medical reason for the item. Allergen-proof mattress covers and humidifiers raise the same issue. Without the required support, an HSA distribution for such an item can be non-qualified and subject to income tax and a penalty.
Family spending raises a different eligibility question. HSA funds can pay for a spouse’s or tax-dependent’s allergy expenses, even when that person is not enrolled in the same health plan.
How the CARES Act changed OTC allergy medication eligibility — and what that does and does not solve
The CARES Act of 2020 permanently removed the prescription requirement for eligible over-the-counter allergy medications bought with FSA or HSA funds. Before that change, patients needed a doctor’s prescription to use those accounts for OTC medicines such as antihistamines and nasal sprays. The change reduced a real barrier to routine care. It amended Internal Revenue Code Sections 223(d) and 106(f), rather than Section 213(d), so account reimbursement should not be confused with the rules for individual itemized medical deductions.
Eligible options include oral antihistamines such as cetirizine, loratadine, fexofenadine, and diphenhydramine, as well as nasal corticosteroid sprays such as fluticasone, triamcinolone, and budesonide. Decongestants, OTC allergy eye drops, and saline nasal rinses also qualify. Purely cosmetic products do not meet the medical-purpose test.
Those medicines suppress symptoms without retraining the immune system or creating lasting tolerance. First-generation antihistamines also cross the blood-brain barrier and block histamine and acetylcholine receptors, with links to sedation and cognitive impairment. Second-generation options are less sedating but can still cause mild cognitive slowing. The financial relief is useful, yet easier access to antihistamines is not access to a cure.
FSA and HSA eligibility for allergy shots: what is covered and how each visit is billed
Allergy shots, also called subcutaneous immunotherapy or SCIT, are qualified FSA and HSA expenses. Eligibility includes the injections, the office visits where they are administered, and patient copayments. Each visit for an injection counts as its own qualified expense. During buildup, visits are usually weekly or biweekly, then monthly during maintenance.
Insurance can substantially change the patient’s share. Insurers commonly cover shots, which can reduce out-of-pocket costs for people with traditional, non-HDHP coverage. Those patients may have an FSA but may not be eligible to contribute to an HSA because HSA eligibility requires an HDHP. For someone with an HDHP and HSA, shots received before the deductible is met are paid out of pocket. Money in an HSA can help pay those costs without using money set aside for everyday spending.
Each visit needs an itemized receipt for the qualified expense and, when insurance is involved, records showing the patient’s share. This does not make shots less eligible. Patients must deal with bills and keep records as they go, especially when buildup visits are more frequent.
Can you use your FSA or HSA for online allergy drops, and what restrictions apply?
Sublingual immunotherapy, or SLIT, drops qualify for FSA, HSA, and HRA reimbursement when supported by a valid physician prescription. Unlike OTC antihistamines under the CARES Act rules, custom drops cannot bypass that prescribing requirement. The prescription establishes the treatment’s medical purpose. It also provides documentation to support the expense if questions arise later. An LPFSA or DCFSA cannot fund drops, even when the prescription is valid.
Custom drops and SLIT tablets are different products. Those tablets are prescription medications and also qualify for FSA and HSA spending. Tax eligibility is separate from insurance coverage. Insurers may cover tablets depending on the plan, but coverage for custom drops is rare, making pre-tax funds a primary payment tool.
An HSA debit card can pay for eligible drops at the point of sale, including online checkout. Alternatively, a patient can pay out of pocket and reimburse the expense from the HSA later. There is no IRS time limit on that reimbursement, provided the expense occurred after the HSA was established and documentation is retained. A patient who starts drops today could claim reimbursement two years later. This flexibility belongs to HSAs, and FSA funds expire.
How the two treatment paths compare in practice when paying with pre-tax funds
Shots come with a separate payment and receipt for each visit, while drops usually have a monthly charge for treatment. For an FSA user, that difference affects how accurately spending can be projected. If the buildup schedule changes near year-end, some planned visits may fall after the deadline for spending the funds. A regular payment for drops is easier to plan around the money left in the account and the plan deadline.
The HSA comparison turns on a different feature. Because funds roll over, patients do not face the same pressure to spend before year-end. Drop patients who pay out of pocket can retain their records, leave HSA funds invested, and reimburse themselves later. Shot expenses also qualify for delayed HSA reimbursement. The particular convenience of drops comes from a more predictable payment schedule and fewer separate transactions.
Insurance coverage for shots can outweigh the convenience of paying for custom drops, which are rarely insured. Clinical fit is also a separate question. Both treatments have been clinically validated and work about as well overall, though some meta-analyses suggest shots help more with certain seasonal allergic rhinitis outcomes.
SLIT’s safety profile is favorable, with predominantly local reactions. The World Allergy Organization has published position papers describing long-term disease modification and sustained benefit after SLIT is discontinued, consistent with the development of immunological tolerance. Those findings support considering drops as treatment. They do not establish that drops are the better clinical choice for every patient.
Why the telehealth delivery model makes SLIT the path of least resistance for FSA and HSA spending
A virtual allergy consultation qualifies under the same medical-purpose standard as an in-office consultation. In a telehealth SLIT pathway, that consultation connects to an at-home allergy test, a physician prescription, and custom drops delivered to the patient. Each step can have a cost that qualifies and comes with records to support it, without a trip to the clinic. The delivery model reduces the administrative load. The patient has fewer payments to handle than with repeated injection appointments, which must be booked and followed by a receipt each time.
This also changes the role of geographic access. In-office shots require a patient to reach the clinic throughout buildup and maintenance, while at-home drops remove that recurring travel requirement. Monthly treatment charges independent of injection appointments make telehealth SLIT the path of least resistance for pre-tax spending.
For FSA users, starting care promptly can also help with year-end planning. When same-day or next-day virtual consultations are available and drops arrive within days, care can start sooner than with in-office buildup visits that take weeks to schedule. Speed gives patients a more direct route from assessment to prescribed treatment, with fewer office-based steps between the decision to seek care and an eligible expense, while the account’s spending deadline still applies.
Practical documentation steps and common mistakes to avoid when claiming allergy care on FSA or HSA
To protect that spending, begin by confirming the account type and its timing rules. An employer account labeled “FSA” is not enough information if it is actually an LPFSA or DCFSA. Check the plan-year deadline, grace period, and carryover rules before working out what treatment will cost. For an HSA, compare the annual contribution limit with what allergy care is expected to cost. Check both how much can go into the account and which expenses qualify.
Keep an itemized receipt for every withdrawal or reimbursement. It should show the product or service name, purchase date, and amount, rather than a generic description such as “pharmacy purchase.” For drops and shots, retain the prescription and the pharmacy or provider receipt. Keep any applicable Explanation of Benefits showing the out-of-pocket portion as well. These records connect the treatment, the payment, and the amount claimed.
Publication 969 tells patients to keep supporting documents with their tax records but does not set a specific three-year period for keeping them. If an HSA reimbursement will be delayed, retain the expense documentation until that later claim can be supported. For household items such as air purifiers and allergen-proof covers, obtain the LMN before purchase. Keep the original signed document naming the diagnosed condition, the item, and why it is medically necessary.
For FSA planning, map monthly drop costs or scheduled shot visits against the plan’s spending window. If money is left near year-end, consider eligible care such as a telehealth consultation or at-home allergy testing, and do not assume that paying for treatment later will meet the deadline. The account rules still govern the claim. Patients who get a proper diagnosis and start appropriate immunotherapy early have more time to put pre-tax funds toward treatment that builds tolerance instead of continuing to spend those dollars on medicines that only suppress symptoms.


